Followers | 34 |
Posts | 2049 |
Boards Moderated | 0 |
Alias Born | 12/03/2013 |
Sunday, September 21, 2014 12:25:58 PM
That are paired with Electroporation and finishing up phase 2 trials in melanoma? No.
You can continue worrying about what another company MIGHT develop and be several years of trials behind ONCS, by the time any of that comes to fruition I'll have been long gone with a 500+ % return.
Let me guess, you passed on investing in Apple 10 years ago because you figured that Samsung was going to introduce the Galaxy in 2012? Brilliant investing strategy.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM